Drug Pricing Reform and Trade Deals Signal Support for Biopharma Innovation

Published on August 15, 2025

Portfolio Manager Dan Lyons and Research Analyst Luyi Guo explain recent developments in proposed pharmaceutical tariffs and “most favored nation” drug pricing and what both could mean for the biopharma industry.

Continue reading on website
Other news

2 ETFs to Capture Upside in Precious & Industrial Metals

August 15, 2025
The 24-hour news cycle reminds investors that tariffs still remain a factor. As such, for those looking to get commodities exposure as a portfolio diversifier will want to make sure they allocate strategically.

July CPI and the Real Inflation Story

August 15, 2025
The July CPI data indicated moderate price inflation and boosted optimism for a September interest rate cut, even though monetary inflation is on the upswing.